Baird Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Sell
4,119
-78
-2% -$21.1K ﹤0.01% 1238
2025
Q4
$1.05M Sell
4,197
-13,246
-76% -$3.52M ﹤0.01% 1233
2025
Q3
$5.01M Buy
17,443
+8,795
+102% +$2.36M 0.01% 736
2025
Q2
$2.27M Buy
8,648
+4,892
+130% +$1.19M ﹤0.01% 977
2025
Q1
$874K Sell
3,756
-29
-0.8% -$7.04K ﹤0.01% 1220
2024
Q4
$868K Sell
3,785
-452
-11% -$104K ﹤0.01% 1218
2024
Q3
$947K Sell
4,237
-5,353
-56% -$1.18M ﹤0.01% 1191
2024
Q2
$1.95M Sell
9,590
-29,772
-76% -$6.06M ﹤0.01% 966
2024
Q1
$8.6M Sell
39,362
-32,763
-45% -$7.22M 0.02% 514
2023
Q4
$16.4M Sell
72,125
-2,463
-3% -$517K 0.04% 353
2023
Q3
$15M Sell
74,588
-15,128
-17% -$3.19M 0.04% 350
2023
Q2
$18.6M Buy
89,716
+74,818
+502% +$14.5M 0.05% 315
2023
Q1
$2.94M Buy
14,898
+271
+2% +$55.8K 0.01% 768
2022
Q4
$2.96M Sell
14,627
-8,867
-38% -$1.73M 0.01% 743
2022
Q3
$4.13M Sell
23,494
-899
-4% -$184K 0.01% 618
2022
Q2
$4.91M Buy
24,393
+1,745
+8% +$372K 0.01% 582
2022
Q1
$5.13M Sell
22,648
-197,776
-90% -$46.5M 0.01% 607
2021
Q4
$59.5M Sell
220,424
-2,160
-1% -$535K 0.14% 174
2021
Q3
$53.8M Buy
222,584
+2,966
+1% +$747K 0.14% 180
2021
Q2
$52M Buy
219,618
+2,361
+1% +$538K 0.14% 180
2021
Q1
$47.6M Buy
217,257
+3,455
+2% +$693K 0.13% 183
2020
Q4
$37.4M Buy
213,802
+85,703
+67% +$14.8M 0.11% 211
2020
Q3
$20.7M Buy
128,099
+60,553
+90% +$9.6M 0.07% 262
2020
Q2
$9.64M Buy
67,546
+48,144
+248% +$6.66M 0.04% 352
2020
Q1
$2.11M Buy
19,402
+3,558
+22% +$513K 0.01% 672
2019
Q4
$2.3M Sell
15,844
-33,695
-68% -$4.86M 0.01% 729
2019
Q3
$7.15M Buy
49,539
+3,284
+7% +$479K 0.03% 424
2019
Q2
$6.87M Buy
46,255
+27,838
+151% +$3.88M 0.03% 434
2019
Q1
$2.42M Buy
18,417
+1,539
+9% +$190K 0.01% 607
2018
Q4
$1.83M Sell
16,878
-1,254
-7% -$168K 0.01% 660
2018
Q3
$2.7M Buy
18,132
+713
+4% +$108K 0.02% 592
2018
Q2
$2.69M Buy
17,419
+101
+0.6% +$15.2K 0.02% 586
2018
Q1
$2.41M Sell
17,318
-3,497
-17% -$514K 0.02% 593
2017
Q4
$2.85M Sell
20,815
-3,443
-14% -$455K 0.02% 537
2017
Q3
$3.15M Sell
24,258
-2,087
-8% -$278K 0.02% 511
2017
Q2
$3.49M Sell
26,345
-12,180
-32% -$1.49M 0.03% 478
2017
Q1
$4.75M Sell
38,525
-195,850
-84% -$23.2M 0.04% 407
2016
Q4
$25.9M Sell
234,375
-206,826
-47% -$23M 0.22% 136
2016
Q3
$52.1M Sell
441,201
-3,424
-0.8% -$403K 0.47% 46
2016
Q2
$49.8M Buy
444,625
+46,425
+12% +$5M 0.46% 50
2016
Q1
$40.1M Sell
398,200
-8,641
-2% -$828K 0.38% 69
2015
Q4
$43.2M Buy
406,841
+36,198
+10% +$3.73M 0.43% 56
2015
Q3
$34.5M Sell
370,643
-6,569
-2% -$680K 0.37% 77
2015
Q2
$39.3M Buy
+377,212
New +$39.3M 0.39% 79

Other funds holding LH

Baird Financial Group's LH Position: Q1 2026 in Review

Baird Financial Group reduced its Labcorp (LH) stake by 1.9% in Q1 2026, selling an estimated $21.1K and leaving 4,119 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1238.

Baird Financial Group first reported a position in LH in Q2 2015 and has held it in 44 quarters since. The position peaked at $59.5M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Baird Financial Group held 4,119 shares of Labcorp worth $1.1M as of Q1 2026.
  • Baird Financial Group sold 78 Labcorp shares in Q1 2026, an estimated $21.1K.
  • Labcorp made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1238 holding.
  • Baird Financial Group first reported a position in Labcorp in Q2 2015 and has held it in 44 quarters since.
  • Baird Financial Group's Labcorp position peaked at $59.5M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.